Listar Bordeaux Population Health Research Center (BPH) - UMR 1219 por autor "BACHELOT, T."
Mostrando ítems 1-3 de 3
-
Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials
LEREBOURS, F.; PULIDO, M.; FOURME, E. ...(British Journal of Cancer. vol. 122, n° 6, pp. 759-765, 2020)Article de revueLibre acceso -
Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort
GOBBINI, E.; EZZALFANI, M.; DIERAS, V. ...(European journal of cancer (Oxford, England. vol. 96, pp. 17-24, 2018-06)Article de revue -
Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort
GRINDA, T.; ANTOINE, A.; JACOT, W. ...(ESMO Open. vol. 6, n° 3, pp. 100114, 2021-04-23)Article de revueLibre acceso